AMA CPT® Assistant - 2026 Issue 7 (July)
Reporting Combination COVID-19 Vaccine Administration
July 2026 page 15 Reporting Combination COVID-19 Vaccine Administration Before 2026, the administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccines were reported using vaccine administration code 90480, which covered all work associated with administration and counseling. However, the emergence of combination vaccine products incorporating COVID-19 vaccine components prompted the need for new coding mechanisms to ensure accurate reporting and appropriate payment. In September 2024, the CPT Editorial Panel (the Panel) approved the revision of code 90480 and the addition of code 90481 to report immunization administration of a vaccine that includes a severe acute respiratory...
Subscribe or sign in to view the full article.
Article Overview
This article reviews CPT 2026 changes affecting immunization administration reporting for vaccines that include a COVID-19 component. It is aimed at coders, billers, and clinicians who need to understand the updated CPT guidance, associated parenthetical notes, and how the changes fit within the Immunization Administration for Vaccines/Toxoids section. The discussion focuses on the policy context, reporting framework, and related administration/counseling considerations without serving as a substitute for the full coding guidance.
Why This Topic Matters
Accurate reporting of vaccine administration is important for compliant claims processing, consistent documentation, and appropriate payment when combination products include a COVID-19 component.
Article Sections
-
July 2026 page 15
Publication and page reference information for the article.
-
Reporting Combination COVID-19 Vaccine Administration
Overview of the CPT update, the reason for the revision, and the broader reporting context for combination vaccine products containing a COVID-19 component.
-
Medicine
The specialty context for the guidance presented in the article.
-
Immunization Administration for Vaccines/Toxoids
Section-level guidance for immunization administration reporting, including related counseling and combination-product considerations.
-
90480
Code-specific guidance and related notes for the primary COVID-19 vaccine administration service.
-
90481
Code-specific guidance and related notes for the add-on administration service used with combination products.
-
Clinical Example (90480)
A brief clinical scenario illustrating use of the primary COVID-19 vaccine administration service.
-
Description of procedure (90480)
Procedural narrative associated with the primary COVID-19 vaccine administration example.
-
Clinical Example (90481)
A brief clinical scenario illustrating use of the add-on service in a combination vaccine setting.
-
Description of Procedure (90481)
Procedural placeholder associated with the add-on service example.
What You Will Learn
- How CPT guidance addresses COVID-19 vaccine administration when combination products are involved.
- What section-level updates were made within immunization administration guidance.
- How the article frames counseling, administration, and combination-vaccine reporting considerations.
- Which types of documentation and clinical scenarios are used to illustrate the updated guidance.
Who Should Read This
- Medical coders
- Billing professionals
- Compliance staff
- Physicians and other qualified health care professionals
- Practice managers
Codes Discussed
Code Ranges Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com
